The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed.

1. Public health disinformation, conflict, and disease outbreaks: a global narrative integrative review to guide new directions for health diplomacy.Global health action · 2025
   Review
2. Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study.BMJ global health · 2025
   Article
3. Why falsified medicines reach patients: an analysis of political and economic factors in Romania.BMJ global health · 2023
   Review
4. The quality of medical products for cardiovascular diseases: a gap in global cardiac care.BMJ global health · 2021
   Article
5. Prevalence of Substandard Amoxicillin Oral Dosage Forms in the National Capital District of Papua New Guinea.The American journal of tropical medicine and hygiene · 2021
   Article
6. Emergency medicine: magnesium sulphate injections and their pharmaceutical quality concerns.Heliyon · 2021
   Article
7. High Rates of Uncontrolled Blood Pressure in Malawian Adults Living with HIV and Hypertension.Global heart · 2021
   Observational
8. Developing a framework regarding a complex risk based methodology in the evaluation of hazards associated with medicinal products sourced via the internet.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
   Article
9. Country Income Is Only One of the Tiles: The Global Journey of Antimicrobial Resistance among Humans, Animals, and Environment.Antibiotics (Basel, Switzerland) · 2020
   Review
10. Recognizing and engaging pharmacists in global public health in limited resource settings.Journal of global health · 2019
    Article
11. Falsified and Substandard Drugs: Stopping the Pandemic.The American journal of tropical medicine and hygiene · 2019
    Review
12. Evaluating the quality of antihypertensive drugs in Lagos State, Nigeria.PloS one · 2019
    Article
13. Eliminating poor quality medicines: 'Caveat emptor, Caveat venditor' (buyer beware, seller beware).International health · 2018
    Article
14. Toward Point-of-Care Drug Quality Assurance in Developing Countries: Comparison of Liquid Chromatography and Infrared Spectroscopy Quantitation of a Small-Scale Random Sample of Amoxicillin.The American journal of tropical medicine and hygiene · 2018
    Article
15. Prescription drug-dispensing limits in the USA-implications for malaria chemoprophylaxis among VFR travellers.Journal of travel medicine · 2018
    Article
16. Quality of medicines in resource-limited settings: need for ethical guidance.Global bioethics = Problemi di bioetica · 2018
    Article
17. A current perspective on antimicrobial resistance in Southeast Asia.The Journal of antimicrobial chemotherapy · 2017
    Article
18. Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi.The American journal of tropical medicine and hygiene · 2017
    Article
19. Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients.Drugs - real world outcomes · 2017
    Article
20. Quantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis.Scientific reports · 2017
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as